Evidence map›Paper›PMID 41013902›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Steric-Adaptive Biocatalysis: Imine Reductase-Mediated Dynamic Kinetic Resolution for Atroposelective Synthesis of Hindered Biaryl Amines.

Zhichao Ni, Jingyuan Zhuang, Yadong Gao, Guangsheng Gao, Zhenling Liu, Ping Su, Gui-Juan Cheng, Li-Cheng Yang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhichao NiState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
Jingyuan ZhuangWarshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, China.
Yadong GaoState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
Guangsheng GaoSchool of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Zhenling LiuState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
Ping SuState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Gui-Juan ChengWarshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, China.
Li-Cheng YangState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.ORCID https://orcid.org/0000-0002-4929-6821

Funding

CAMS Innovation Fund for Medical Sciences (CIFMS) 2023-I2M-2-006Chinese Medicine Resources 2060302Guangdong Basic and Applied Basic Research Foundation 2023B1515020052National Natural Science Foundation of China 22173077National Natural Science Foundation of China 22371302National Natural Science Foundation of China 22422110Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2022-RC350-03Shenzhen Science and Technology Program RCYX20200714114736199
6 · The paper itself

Abstract

As an efficient and environmentally benign strategy, enzymatic catalysis has emerged with high reactivity and selectivity for atropisomeric structures. Atropisomeric biaryl amines are of great importance in drug development and asymmetric catalysis. However, substrates with steric hindrance are often poorly accepted by enzymes, as the immense pockets required are not commonly found in wild-type enzymes. In this work, an imine reductase (IRED)-catalyzed dynamic kinetic resolution (DKR) strategy is introduced for the synthesis of atropisomeric biaryl amines, especially those with bulky substitutions on (hetero)aryls, including naphthalene- and quinoline-containing biaryl scaffolds. A broad range of atropisomeric biaryl amines are obtained in up to 99% yield and 99% ee, enabled by the steric adaptability of IR-09. Besides, a borrowing hydrogen cascade system is explored to extend the construction of atropisomeric biaryl amines directly from racemic alcohols. Density functional theory (DFT) calculations and molecular dynamics (MD) simulations are carried out to elucidate the DKR process, selectivity of IR-09, and interactions between the sterically hindered substrates and residues within the enzyme.

Indexed as

AminesIminesOxidoreductasesBiocatalysisKineticsMolecular Dynamics SimulationStereoisomerismAminesIminesOxidoreductasesbiaryl amineborrowing hydrogen cascadedynamic kinetic resolutionimine reductasemolecular dynamics simulation

Identifiers

PMID41013902
PMCPMC12677705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.